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Abstract
Background: Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with both HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP), which is a chronic neuroinflammatory disease, and adult T-cell leukemia
(ATL). The pathogenesis of HAM/TSP is known to be as follows: HTLV-1-infected T cells trigger a hyperimmune response
leading to neuroinflammation. However, the HTLV-1-infected T cell subset that plays a major role in the accelerated immune
response has not yet been identified.
Principal Findings: Here, we demonstrate that CD4
+CD25
+CCR4
+ T cells are the predominant viral reservoir, and their levels
are increased in HAM/TSP patients. While CCR4 is known to be selectively expressed on T helper type 2 (Th2), Th17, and
regulatory T (Treg) cells in healthy individuals, we demonstrate that IFN-c production is extraordinarily increased and IL-4, IL-
10, IL-17, and Foxp3 expression is decreased in the CD4
+CD25
+CCR4
+ T cells of HAM/TSP patients as compared to those in
healthy individuals, and the alteration in function is specific to this cell subtype. Notably, the frequency of IFN-c-producing
CD4
+CD25
+CCR4
+Foxp3
2 T cells is dramatically increased in HAM/TSP patients, and this was found to be correlated with
disease activity and severity.
Conclusions: We have defined a unique T cell subset—IFN-c
+CCR4
+CD4
+CD25
+ T cells—that is abnormally increased and
functionally altered in this retrovirus-associated inflammatory disorder of the central nervous system.
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Introduction
Human T-lymphotropic virus type 1 (HTLV-1) is a human
retrovirus associated with chronic and persistent infection of human
T cells. While the majority of infected individuals remain healthy
lifelong asymptomatic carriers, approximately 3–5% develop
aggressive mature T-cell malignancy termed adult T-cell leukemia
(ATL) and another 0.25–3% develop a chronic neuroinflammatory
disease termed HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) [1–4]. Furthermore, in some HAM/TSP
patients, other autoimmune diseases characterized by multiorgan
lymphocytic infiltrates, including uveitis, Sjo ¨gren syndrome,
arthritis, polymyositis, and alveolitis have been reported [5,6].
HAM/TSP patients have high frequency of HTLV-1-infected T
cells, heightened viral gene expression (in particular, the expression
of the viral transactivating gene tax), and virus-specific immune
responses, including increased production of proinflammatory
cytokines such as IL-6, IL-12, and IFN-c [7–9]. Neuropathological
findings have demonstrated focal infiltrates of HTLV-1-infected
CD4
+ T cells, CD8
+ T cells, and macrophages in the central
nervous system (CNS) [10]. It has been suggested that together with
viral gene expression and cellular signaling mechanisms, HTLV-1-
infectedT cellstriggerastrongvirus-specificTcellresponse,leading
to CNS inflammation and autologous tissue damage. We
hypothesized [11,12] that these ‘‘pathogenic’’ HTLV-1-infected T
cells may trigger chronic hyperimmune responsiveness in HAM/
TSPpatients,and thus theymightbeanimportanttargetforclinical
therapeutic interventional strategies.
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6517HTLV-1 has been reported to infect a number of cell types in
vitro and in vivo [13–16]. In our previous study, we used
molecular and immunological techniques to demonstrate that
CD4
+CD25
+ T cells are the predominant viral reservoir in the
peripheral blood [12]. In healthy individuals, subsets of
CD4
+CD25
+ T cells, termed regulatory T cells or Treg cells,
has been demonstrated to be hyporesponsive to antigenic
stimulation and is reported to suppress the proliferation and
cytokine production of CD4
+CD25
2 and CD8
+ effector T cells in
vitro [17]. Although Treg cells are phenotypically similar to
activated T cells, they can be identified ex vivo by the intracellular
expression of the transcriptional regulator Foxp3 [18], which is
critical for the development and function of Treg cells in both mice
and humans [17]. Previous studies have observed significant
reductions in Foxp3 expression and/or Treg function in several
human autoimmune diseases, including multiple sclerosis (MS),
myasthenia gravis, and type I diabetes [17,19], suggesting that
defects in Foxp3 expression and/or Treg function may precipitate
the loss of immunological tolerance. In our recent study, we
reported that CD4
+CD25
+ T cells from HAM/TSP patients
exhibited reduced Foxp3 expression levels compared to healthy
individuals and that this reduction was associated with a loss of
suppressor function [20]. Furthermore, overexpression of a single
HTLV-1 gene (tax) was capable of reducing Foxp3 expression and
dampening the suppressive function of healthy donor
CD4
+CD25
+ T cells [20]. These observations suggest that
persistent T cell activation in HAM/TSP patients triggered by
viral antigens, e.g., HTLV-1 tax, that are associated with Foxp3
downregulation may result in decline of the CD4
+CD25
+Foxp3
+
Treg cell population and accumulation of CD4
+CD25
+Foxp3
2 T
cells that lack suppressive function but are capable of exacerbating
the disease process. Therefore, we hypothesize that in HAM/TSP
patients, the Foxp3
2 HTLV-1-infected CD4
+CD25
+ T cells may
contain an immunopathogenic T cell subset that can accelerate
the immune response. Thus far, however, the role of Foxp3-
negative CD4
+CD25
+ T cells has not been addressed in the
pathogenesis of HAM/TSP.
To detect these HAM/TSP ‘‘pathogenic T cell’’ subsets from
the pool of HTLV-1-infected T cells, it was important to define
additional immunological markers of HTLV-1 infection in HAM/
TSP patients. Although ATL cells have also been shown to have
HTLV-1-infected CD4
+ cells with high expression of CD25
+ [21],
a recent study demonstrated that ATL cells expressed the
chemokine receptor CCR4, which is known to be selectively
expressed on T helper type 2 (Th2) cells and Treg cells subsets
[22]. More recently, it has been observed that CCR4 is expressed
on Th17 cells [23]. Furthermore, it has been reported that HTLV-
1 preferentially transmits to CCR4
+CD4
+ T cells through the
CCR4 ligand (CC chemokine ligand (CCL) 22), which is induced
by tax and consequently expressed on the surface of HTLV-1-
infected T cells [24]. However, it has been demonstrated that in
HAM/TSP patients, HTLV-1-infected CD4
+CD25
+ T cells
produce the Th1 cytokine IFN-c and contain fewer Foxp3
+ Treg
cells [20]. Therefore, it would be of interest to determine the
percentage of CCR4-expressing cells in the HAM/TSP
CD4
+CD25
+ subset and whether CCR4 can be used as a marker
of HTLV-1-infected T cells in HAM/TSP.
In the present study, we demonstrated that CD4
+CD25
+CCR4
+T
cells are the main reservoir for HTLV-1 in HAM/TSP patients.
While CD4
+CD25
+CCR4
+ Tc e l l si nA T Ls h o w e dh i g hF o x p 3
expression (Treg), this subset showed low Foxp3 expression in HAM/
TSP, and this Foxp3
2 T cell subset actively proliferated in HAM/
TSP patients. Notably, the CD4
+CD25
+CCR4
+ Tc e l l si nH A M /
TSP patients were producing extraordinarily high levels of IFN-c,
while this T cell subset produced low levels of IFN-c in healthy
donors. Furthermore, the expression levels of IL-2, IL-4, IL-10, and
IL-17in the CD4
+CD25
+CCR4
+T cellsin HAM/TSP patients were
low compared to the corresponding levels produced by this T cell
subset in healthy individuals. Further, it is noteworthy that these
functional alterations were specific to the CD4
+CD25
+CCR4
+ Tc e l l
subtype (HTLV-1-infected T cells). Moreover, the frequency of these
IFN-c-producing CD4
+CD25
+CCR4
+Foxp3
2 Tc e l l sw a si n c r e a s e d
and found to be correlated with disease severity in HAM/TSP
patients. Thus, our study is the first to demonstrate that abnormal
IFN-c-producing CCR4
+CD4
+CD25
+ T cells, which are rare in
healthy individuals, are increased in HTLV-1-infected T cells in
HAM/TSP patients.
Results
CD4
+CD25
+CCR4
+ T cells are the main reservoir of HTLV-1
and are present in high numbers in HAM/TSP patients
To determine whether CCR4 can be used as a cell surface markerto
identify HTLV-1-infected T cells in HAM/TSP patients as reported in
ATL cells [22], we separated peripheral blood mononuclear cells
(PBMCs) from HAM/TSP patients into the following T cell subtypes
by FACS sorting: CD4
+CD25
2CCR4
2,C D 4
+CD25
2CCR4
+,
CD4
+CD25
+CCR4
2,a n dC D 4
+CD25
+CCR4
+ (Figure 1A). The
purity of each separated cell subtype was approximately 99% (Figure
S1). The HTLV-1 proviral DNA load was then determined within
each population by real-time quantitative PCR. As shown in Figure 1B
(means of 8 HAM/TSP patients), the HTLV-1 proviral DNA load was
higher in CD4
+CD25
+ T cells than in CD4
+CD25
2 T cells; this result
is consistent with those of previous studies [12]. Moreover, when
CCR4 was used to segregate these T cell subsets, increased HTLV-1
provirus levels were also observed in CD4
+CCR4
+ cells, including
CD25
2 cells. Importantly, the CD4
+CD25
+CCR4
+ Tc e l ls u b s e tw a s
infected with HTLV-1 at significantly higher frequencies than for the
CD4
+CD25
+CCR4
2 T cell subset (p=0.017). If the HTLV-1
provirus integrates at the rate of 1 copy per cell [14,25], the proviral
DNA load (115.65635.28 copies/100 cells) in CD4
+CD25
+CCR4
+ T
cells suggests that the majority (if not all cells) of this population is
infected with HTLV-1.
These results directly demonstrated that CD4
+CD25
+CCR4
+ T
cells are the main virus reservoir in HAM/TSP patients; therefore,
we aimed to determine the percentage of this T cell subset in the
PBMCs to the total HTLV-1 proviral DNA in each HAM/TSP
patient. As shown in Figure 1C, the amount of HTLV-1 proviral
DNA (which is the percent of HTLV-1-infected cells in PBMCs,
provided the provirus integrates at the rate of 1 copy per cell) and
the percentage of CD4
+CD25
+CCR4
+ T cells were comparable in
the HAM/TSP patients with low to medium HTLV-1 viral loads
(HAM 1, HAM 5, HAM 6, HAM 4, HAM 7, and HAM 2). In the
HAM/TSP patients with higher virus loads (HAM 10 and 11), the
number of virus-infected cells (virus load) was demonstrated to be
higher than the percentage of CD4
+CD25
+CCR4
+ T cells,
suggesting that other cell populations may also be infected in
these patients.
As shown in the histogram plot in Figure 1A, CD4
+CD25
+CCR4
+
cells exhibited a high peak while CD4
+CD25
+CCR4
2 and
CD4
+CD25
2CCR4
+ cells exhibited low peaks in a representative
HAM/TSP patient. To analyze whether this increased frequency is
specific to the cell subtype, we analyzed the frequency of each cell
population in 8 healthy donors (HD) and 11 HAM/TSP patients
(Figure 1D). CD4
+CD25
+CCR4
+ cells were significantly increased
(p=0.001) and CD4
+CD25
+CCR4
2 cells were slightly increased
(p=0.045) in the HAM/TSP patients compared to the respective
values in the HDs. Furthermore, the CD4
+CD25
2CCR4
+/2 cell
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6517Figure 1. CD4
+CD25
+CCR4
+ T cells are the main reservoir for HTLV-1 and are present in increased levels in HAM/TSP patients. A.
Representative plot of FACS sorting. CD4
+CD25
2CCR4
2, CD4
+CD25
2CCR4
+, CD4
+CD25
+CCR4
2, and CD4
+CD25
+CCR4
+ T cells were separated by
FACS. The purity of each cell population was approximately 99% (Figure S1). B. HTLV-1 proviral DNA load of PBMCs and CD4
+CD25
2CCR4
2,
CD4
+CD25
2CCR4
+, CD4
+CD25
+CCR4
2, and CD4
+CD25
+CCR4
+ T cells were assessed using quantitative PCR in 8 HAM/TSP patients. Data are presented
as mean6SE. The HTLV-1 proviral load was significantly higher in the CD4
+CD25
+CCR4
+ T cells than in the CD4
+CD25
+CCR4
2 T cells (p=0.017 by the
Wilcoxon signed-rank test). C. HTLV-1 proviral DNA load in PBMCs and the percentages of CD4
+CD25
+CCR4
+ T cells in the PBMCs of 8 HAM/TSP
patients. D. The frequency of CD4
+CD25
2CCR4
2, CD4
+CD25
2CCR4
+, CD4
+CD25
+CCR4
2, and CD4
+CD25
+CCR4
+ T cells in HDs and HAM/TSP patients.
The frequency of CD4
+CD25
2CCR4
2, CD4
+CD25
2CCR4
+, CD4
+CD25
+CCR4
2, and CD4
+CD25
+CCR4
+ T cells in 8 HDs and 11 HAM/TSP patients was
analyzed by FACS and represented as the frequency of each cell population. Data are presented as mean6SE. The P value was calculated by unpaired
Student’s t test.
doi:10.1371/journal.pone.0006517.g001
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
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HDs. Overall, the CD4
+CD25
+CCR4
+ T cells were preferentially
infected by HTLV-1, and they were found in higher numbers in
HAM/TSP patients.
Foxp3-negative CD4
+CD25
+CCR4
+ T cells are higher in
HAM/TSP patients than in healthy donors
Although CCR4 is known to be selectively expressed on Th2,
Th17, and Treg cells [23,26] in healthy individuals, the expression
levels of Foxp3, a hallmark of Treg cells [17,18], has been reported
to be reduced in HAM/TSP patients [20,27–29]. Therefore, it is
interesting to compare the Foxp3 expression levels in
CD4
+CD25
+CCR4
+ T cells between HAM/TSP patients, ATL
patients, and uninfected healthy donors (HDs). As reported
previously [30], only the CCR4
+ subset of CD4
+CD25
+ cells
expressed Foxp3
+, whereas CD4
+CD25
2 cells in HD did not
express Foxp3 (upper panels, Figure 2). Foxp3 expression in
CD4
+CD25
+CCR4
+ T cells was reduced in HAM/TSP patients
and increased in ATL patients (Figure 2); this finding is in line with
the results of previous studies regarding CD4
+CD25
+ T cells from
HAM/TSP and ATL patients [27–29,31]. The slightly elevated
Foxp3 expression in the CD4
+CD25
2 population of ATL patients
(lower right panel, Figure 2) may reflect the presence of leukemia
cells. However, a more detailed analysis of these FACS plots
demonstrated an increased number of Foxp3
2 cells in the
CD4
+CD25
+CCR4
+ subset in HAM/TSP patients (arrow,
Figure 2). This observation suggested that the number of
CD4
+CD25
+CCR4
+Foxp3
2 T cells may be increased in HAM/
TSP patients.
Analysis of these T cell subsets based on Foxp3 expression in
CD4
+CD25
+CCR4
+ cells demonstrated a significant elevation in
the frequency of CD4
+CD25
+CCR4
+Foxp3
2 T cells in the total
PBMCs in HAM/TSP patients (n=11) as compared to that in
HDs (n=8) (left panel, Figure 3A; p=0.001). The percentage of
Foxp3
2 cells in the CD4
+CD25
+CCR4
+ subset was also higher in
HAM/TSP patients than in HDs (left panel, Figure 3B; p=0.002).
Further, the percentage of Foxp3
+ cells in this subset was
decreased in HAM/TSP patients than in HDs (right panel,
Figure 3B; p=0.002), and the frequency of Foxp3
+ cells in this
subset in the total PBMCs was equivalent in HAM/TSP patients
and HDs (right panel, Figure 3A; p=0.817).
To determine whether increased CD4
+CD25
+CCR4
+Foxp3
2
T cells in HAM/TSP patients were proliferating in vivo, we
examined the expression levels of Foxp3 and Ki67 in
CD4
+CD25
+CCR4
+ T cells. Ki67 is a marker of proliferating
cells. As shown in Figure 3C, Ki67-positive cells were predom-
inantly confined to the CD4
+CD25
+CCR4
+Foxp3
+ T cells
(defined as Treg cells) in HDs and ATL patients. On the other
hand, CD4
+CD25
+CCR4
+Foxp3
2 T cells were preferentially
positive for Ki67 in HAM/TSP patients, suggesting that the
CD4
+CD25
+CCR4
+Foxp3
2 T cells were proliferating in vivo.
Collectively, these results indicate that Foxp3 expression in
HTLV-1-infected CD4
+CD25
+CCR4
+ T cells is suppressed in
HAM/TSP patients; this results in the accumulation and
proliferation of the CD4
+CD25
+CCR4
+Foxp3
2 T cell subset.
CD4
+CD25
+CCR4
+Foxp3
2 T cells produce multiple
proinflammatory cytokines and overproduce IFN-c in
HAM/TSP
CCR4-expressing CD4
+ T cells include Th2, Th17, and Treg
cells, and they do not tend to produce Th1 cytokines such as IFN-
c in healthy individuals [26]. However, it has been reported that
HTLV-1-infected CD4
+ T cells in HAM/TSP patients can
produce IFN-c [20,32]. Therefore, we investigated the intracel-
lular proinflammatory cytokine expression in the
CD4
+CD25
+CCR4
+ T cells in 8 HDs, 11 HAM/TSP patients,
and 5 ATL patients after phorbol 12-myristate 13-acetate (PMA)
and ionomycin stimulation and compared the expression levels
with those of Foxp3 (Figure 4A, B). Interestingly, the expression of
IFN-c, IL-2, and IL-17 was observed only in the Foxp3-negative
population of CD4
+CD25
+CCR4
+ T cells but not in the Foxp3-
positive population (Treg cells) of CD4
+CD25
+CCR4
+ T cells in
HDs (Figure 4A). In HAM/TSP patients, IFN-c production was
demonstrated in the Foxp3-negative population of the
CD4
+CD25
+CCR4
+ T cells and was found to be significantly
increased compared to that in HDs, while IL-2 and IL-17
production was decreased in HAM/TSP patients than in HDs. In
ATL patients, although PMA and ionomycin stimulation reduced
the Foxp3 expression levels (lower left panel, Figure 2), the
expression of all 3 cytokines in CD4
+CD25
+CCR4
+ T cells was
significantly decreased (Figures 4A, B).
Results of the intracellular flow cytometry revealed that
CD4
+CD25
+CCR4
+Foxp3
2 T cells exhibited increased IFN-c
expression and decreased IL-2 and IL-17 expression in HAM/
TSP. Therefore, we wished to determine whether comparable
changes in the mRNA expression of cytokines could also be
demonstrated using PBMCs before culture. Therefore,
CD4
+CD25
+CCR4
+ T cells from PBMCs of 3 HDs, 4 HAM/
TSP patients, and 3 ATL patients were isolated by FACS sorting,
and the mRNA expression levels of IFN-c, IL-2, and IL-17 were
quantified by real-time RT-PCR (Figure 4C). These results were
in agreement with those of the cytokine protein expression
obtained by flow cytometry (Figures 4A, B). The mRNA
expression of IFN-c in CD4
+CD25
+CCR4
+ T cells was increased
in HAM/TSP patients than in the HDs (Figure 4C). Similarly, IL-
2 and IL-17 mRNA levels in CD4
+CD25
+CCR4
+ T cells were
decreased in HAM/TSP patients than in the HDs (Figures 4A, B).
Collectively, these results indicate that the differential production
of proinflammatory cytokines in CD4
+CD25
+CCR4
+ cells is
dependent on the Foxp3 expression level. In HAM/TSP patients,
HTLV-1-infected CD4
+CD25
+CCR4
+Foxp3
2 T cells overpro-
duce IFN-c and produce low levels of IL-17.
CD4
+CD25
+CCR4
+ T cells in HAM/TSP produce low levels
of IL-4 and IL-10
Although the overproduction of IFN-c in CD4
+CD25
+CCR4
+
T cells of HAM/TSP patients was demonstrated (Figure 4), it was
also of interest to determine whether the production of suppressive
cytokines such as IL-4 and IL-10 was decreased in these cells
because the CD4
+CD25
+CCR4
+ T cells in healthy donors mainly
include Th2 and Treg cells [26]. This T cell subset was separated
from PBMCs by FACS sorting from 4 HDs and 4 HAM/TSP
patients, and the IL-4 or IL-10 mRNA expression levels were
analyzed by real-time RT-PCR. As shown in Figure 5A,
CD4
+CD25
+CCR4
+ T cells in HAM/TSP produced lower levels
of IL-4 and IL-10 than in HDs.
Furthermore, to examine whether these functional alterations in
the CD4
+CD25
+CCR4
+ T cells from HAM/TSP patients are
specific to the cell subtype, we investigated the intracellular
cytokine expression of IFN-c, IL-17, and IL-10 in each of the 4 cell
subtypes from 8 HDs and 7 HAM/TSP patients by FACS after
PMA and ionomycin stimulation (Figure 5B). In
CD4
+CD25
+CCR4
+ T cells, the percentage of IFN-c-producing
cells was low and that of IL-10- and IL-17-producing cells was
high in HDs, whereas the percentage of IFN-c-producing cells was
increased and that of IL-10- and IL-17-producing cells was
decreased in HAM/TSP patients, confirming the results presented
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6517Figure 2. Different expression levels of FoxP3 in CD4
+CD25
+CCR4
+ T cells between HD, HAM/TSP, and ATL. PBMCs from 1 healthy
donor (HD 1), 2 HAM/TSP patients (HAM 6, HAM 11), and 1 ATL patient (ATL 1) were stained for CD4, CD25, CCR4, and intracellular Foxp3. CD4
+CD25
+
or CD4
+CD25
2 cells were gated, and the expression levels of CCR4 and Foxp3 were plotted. The percentages of CCR4
+Foxp3
+ cells and CCR4
+Foxp3
2
cells in CD4
+CD25
+ or CD4
+CD25
2 cells are indicated in each panel. The arrow indicates the increased number of cells with low Foxp3 expression
levels in HAM/TSP CD4
+CD25
+CCR4
+ T cells.
doi:10.1371/journal.pone.0006517.g002
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6517Figure 3. The Foxp3-negative CD4
+CD25
+CCR4
+ T cells are higher in HAM/TSP patients than in healthy donors. A. Percentage of the
CD4
+CD25
+CCR4
+Foxp3
2 or CD4
+CD25
+CCR4
+Foxp3
+ T cells in the total PBMCs in HD and HAM/TSP patients. PBMCs from 8 HD and 11 HAM/TSP
patients were stained for CD4, CD25, CCR4, and intracellular Foxp3. The percentage of CD4
+CD25
+CCR4
+Foxp3
2 (left panel) or
CD4
+CD25
+CCR4
+Foxp3
+ (right panel) T cells to the total PBMCs was calculated by FACS analysis. The horizontal bar indicates the mean value of
each group. An unpaired Student’s t test was used for statistical analysis. B. Percentage of the Foxp3
2 or Foxp3
+ population in CD4
+CD25
+CCR4
+ T
cells. PBMCs from 8 HDs and 11 HAM/TSP patients were stained for CD4, CD25, CCR4, and intracellular Foxp3. Then, the percentage of the Foxp3
2
(left panel) or Foxp3
+ (right panel) population in CD4
+CD25
+CCR4
+ T cells was calculated. The horizontal bar indicates the mean value of each group.
The percentage of the Foxp3
2 population in CD4
+CD25
+CCR4
+ T cells was significantly higher in the HAM/TSP patients than in the HDs (p=0.002,
unpaired Student’s t test), and the percentage of the Foxp3
+ population in the CD4
+CD25
+CCR4
+ T cells was significantly lower in the HAM/TSP
patients than in the HDs (p=0.002, unpaired Student’s t test). C. Foxp3 and Ki67 expression in CD4
+CD25
+CCR4
+ T cells from HD 1, HAM 11, and ATL
1. CD4
+ T cells were negatively separated by magnetic beads and stained for CCR4, CD25, and intracellular Foxp3 and Ki67. CD25
+CCR4
+ cells were
gated, and the expression levels of Ki67 and Foxp3 were plotted.
doi:10.1371/journal.pone.0006517.g003
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e6517Figure 4. CD4
+CD25
+CCR4
+Foxp3
2 T cells produce multiple proinflammatory cytokines and overproduce IFN-c in HAM/TSP. A.
Representative proinflammatory cytokine expression in CD4
+CD25
+CCR4
+ T cells from HDs, HAM/TSP patients, and ATL patients. CD4
+ T cells were
negatively separated by magnetic beads, and stimulated for 5 h with PMA and ionomycin in the presence of monensin. The cells were then stained
for CCR4, CD25, intracellular Foxp3, and IFN-c or IL-2 or IL-17A. The CD25
+CCR4
+ cells were gated, and the expression levels of each cytokine and
Foxp3 were plotted. Numbers adjacent to the outlined area indicate the percentage of cytokine-producing cells in the CD4
+CD25
+CCR4
+ T cell
subset. B. The percentage of proinflammatory cytokine (IFN-c, IL-17A, and IL-2) expression in CD4
+CD25
+CCR4
+ T cells from 8 HDs, 11 HAM/TSP
patients, and 5 ATL patients. The horizontal bar indicates the mean value of each group. Scheffe’s test (nonparametric) was used for statistical
analysis. n.s. not significant. C. Real-time RT-PCR of IFN-c, IL-17A, and IL-2 mRNA in CD4
+CD25
+CCR4
+ T cells separated by FACS sorting from 3 HDs, 4
HAM/TSP patients, and 3 ATL patients. Data are presented as mean6SE.
doi:10.1371/journal.pone.0006517.g004
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observed in other cell subtypes (Figure 5B), and this functional
alteration in cytokine production was specific to the
CD4
+CD25
+CCR4
+ T cells of HAM/TSP patients.
Increased HTLV-1 tax expression in CD4
+CD25
+CCR4
+
cells of HAM/TSP patients
Our results demonstrated differential proinflammatory cytokine
production in CD4
+CD25
+CCR4
+ cells between HAM/TSP and
ATL that is dependent on the level of Foxp3 expression (Figure 4).
S i n c ew eh a v ep r e v i o u s l yd e m o n s t r a t e dt h a tH T L V - 1tax can reduce
Foxp3 expression [20], it is possible that the intracellular expression of
HTLV-1 may function to direct T cell differentiation from Treg cells
(Foxp3
+ and no cytokine production) into non-Treg cells (Foxp3
2
with inflammatory cytokine production). Therefore, we analyzed the
differences in the HTLV-1 DNA load and the HTLV-1 tax expression
of CD4
+CD25
+CCR4
+ T cells between HAM/TSP and ATL
patients. We isolated the CD4
+CD25
+CCR4
+ T cells from the
PBMCs of HAM/TSP and ATL patients and quantified the HTLV-1
provirus DNA load and HTLV-1 tax mRNA expression by real-time
PCR and RT-PCR, respectively. As shown in Figure 6, while the
HTLV-1 provirus DNA loads between the 2 groups were equivalent,
the HTLV-1 tax mRNA expression in CD4
+CD25
+CCR4
+ Tc e l l s
was significantlyincreased in the HAM/TSP patients than in the ATL
patients.
The frequency of IFN-c producing CD4
+CD25
+CCR4
+ T
cells correlates with disease severity in HAM/TSP
In this study, we demonstrated that IFN-c production is
specifically increased in the CD4
+CD25
+CCR4
+ T cells in HAM/
TSP patients (Figures 4 and 5). We then measured the percentages
of the IFN-c-producing CD4
+CD25
+CCR4
+ T cells to the total
PBMCs in 8 HDs, 11 HAM/TSP, and 5 ATL patients. As shown
in Figure 7A, the frequency of this population was significantly and
specifically increased in HAM/TSP patients than in HDs
(p,0.01) and ATL patients (p,0.05).
Figure 5. CD4
+CD25
+CCR4
+ T cells in HAM/TSP produce lower levels of IL-4 and IL-10. A. Decreased mRNA expression levels of IL-4 and IL-
10 in CD4
+CD25
+CCR4
+ T cells from HAM/TSP patients. CD4
+CD25
+CCR4
+ T cells were separated by FACS sorting from 4 HDs and 4 HAM/TSP patients,
and the IL-4 or IL-10 mRNA expression levels were analyzed by real-time RT-PCR. Data are presented as mean6SE. B. The percentage of cytokine (IFN-
c, IL-10, and IL-17A)-expressing cells in each cell subtype between HDs and HAM/TSP patients. CD4
+ T cells were separated using magnetic beads
from PBMC of 8 HDs and 7 HAM/TSP patients, and stimulated by PMA and ionomycin for 5 hours in the presence of monensin. Then, the percentage
of IFN-c-, IL-10-, and IL-17-positive cells in each cell population was determined by FACS. Data are presented as mean6SE. The P value was calculated
by unpaired Student’s t test. n.s. not significant.
doi:10.1371/journal.pone.0006517.g005
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in the pathogenesis of HAM/TSP, we aimed to analyze whether the
frequency of IFN-c-producing CD4
+CD25
+CCR4
+ T cells was
correlated with disease activity. Therefore, we studied the correlation
between the frequency of IFN-c-producing CD4
+CD25
+CCR4
+ T
cells with a HAM/TSP clinical severity score and the concentration
of neopterin in CSF. Neopterin is known to be a marker of active
inflammation in the spinal cord lesions of HAM/TSP patients
[33,34]. The frequency of IFN-c-producing CD4
+CD25
+CCR4
+ T
cells correlated with disease severity (Figure 7B, p=0.018) and CSF
neopterin concentrations (Figure 7C, p=0.011), while the HTLV-1
provirus DNA load in PBMCs did not correlate with disease severity
and CSF neopterin concentrations (p=0.351 and p=0.358,
respectively). It is notable that in the patients with low grade disease
severity and high virus load (indicated by * in Figure 7B), the IFN-c
production in HTLV-1-infected T cells (CD4
+CD25
+CCR4
+)w a s
low. These results suggest that the number of functionally altered
(IFN-c producing) HTLV-1-infected T cells rather than the absolute
number of HTLV-1-infected T cells is more important as a
correlating factor for HAM/TSP disease activity and prognosis.
Removal of CD4
+CD25
+CCR4
+ T cells decreases
spontaneous proliferation of PBMCs from HAM/TSP
patients
Although Th2 and Treg CD4
+CD25
+CCR4
+ T cells in healthy
individuals are known to be immunosuppressive [26], we
demonstrated that in HAM/TSP patients, HTLV-1-infected
CD4
+CD25
+CCR4
+ T cells overproduce Th1 cytokines such as
IFN-c and produce low levels of suppressive cytokines such as IL-4
and IL-10. Therefore, we determined if the CD4
+CD25
+CCR4
+
T cells in HAM/TSP patients were also functionally immunosup-
pressive. Because the HAM/TSP PBMCs are known to proliferate
spontaneously without any mitogenic stimuli [35], PBMCs,
PBMCs lacking CD4
+CD25
+CCR4
+ T cells, and PBMCs lacking
CD4
+CD25
2CCR4
2 T cells were prepared using FACS sorting
from 4 HDs and 4 HAM/TSP patients and cultured for 7 days,
after which the magnitude of proliferation between the 2 groups
was compared. As shown in Figure 8A, spontaneous proliferation
of HAM PBMCs was significantly reduced in the PBMCs lacking
CD4
+CD25
+CCR4
+ T cells (p=0.026) but not in the PBMCs
lacking CD4
+CD25
2CCR4
2 T cells. In healthy donors, no
difference in spontaneous proliferation was observed between
PBMCs lacking CD4
+CD25
+CCR4
+ T cells and those lacking
CD4
+CD25
2CCR4
2 T cells (Figure 8A). This result suggests that
CD4
+CD25
+CCR4
+ T cells are a necessary component of the
observed spontaneous lymphoproliferative response in the PBMCs
of HAM/TSP patients.
We then examined the proliferation ability of CD4
+CD25
+CCR4
+
T cells in HAM/TSP patients. We separated CD4
+CD25
+CCR4
+ T
cells and CD4
+CD25
2CCR4
2 Tc e l l sf r o m4H D sa n d4H A M / T S P
patients by FACS sorting and cultured them for 7 days, following
which we compared the magnitude of proliferation between these cell
populations (Figure 8B). CD4
+CD25
+CCR4
+T cells from HAM/TSP
patients proliferated independently, while CD4
+CD25
2CCR4
2 T
cells from HAM/TSP patients and CD4
+CD25
+CCR4
+ and
CD4
+CD25
2CCR4
2 T cells from HDs did not.
Discussion
HAM/TSP is a neuroinflammatory disorder etiologically
associated with a human retrovirus (HTLV-1). The pathogenesis
of this disorder has been demonstrated to involve HTLV-1-
infected T cells, which induce chronic hyperimmune responses
that can lead to an immunopathological process in the CNS of
genetically susceptible infected individuals [11,36]. We hypothe-
sized that there may exist subpopulations of chronically activated
‘‘pathogenic T cells’’ in HTLV-1-infected cells of HAM/TSP
patients that may function to accelerate inflammation and that
these cells could be an important target for clinical therapeutic
interventions. It was important to initially determine markers of
HTLV-1-infected T cells in HAM/TSP patients. In our previous
studies, we have demonstrated that CD4
+CD25
+ T cells are the
predominant viral reservoir in the peripheral blood of HAM/TSP
patients [12], although CD8
+ T cells [14], macrophages [13,16]
and dendritic cells [15] are also infected in HAM/TSP. Recently,
the chemokine receptor CCR4 has been shown to be expressed on
HTLV-1-infected ATL cells [22]. Since CCR4 is known to be
selectively expressed on Th2, Th17, and Treg cells [23,26], and
since ATL cells have been shown to express high levels of Foxp3, a
specific marker of Treg [22,31], it was hypothesized that ATL cells
may be derived from Treg [37]. However, in HAM/TSP patients,
Figure 6. Increased HTLV-1 tax expression in CD4
+CD25
+CCR4
+ cells from HAM/TSP patients. HTLV-1 proviral DNA load and HTLV-1 tax
expression in CD4
+CD25
+CCR4
+ cells from HAM/TSP and ATL patients. The HTLV-1 proviral DNA load was measured in the CD4
+CD25
+CCR4
+ cells
from HAM/TSP and ATL patients (left panel, n=3), and the HTLV-1 tax mRNA expression (right panel, HAM: n=4, ATL: n=3) was quantitatively
measured. Data are presented as mean6SE.
doi:10.1371/journal.pone.0006517.g006
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PLoS ONE | www.plosone.org 9 August 2009 | Volume 4 | Issue 8 | e6517Figure 7. Frequency of IFN-c-producing CD4
+CD25
+CCR4
+Foxp3
2 T cells is increased and correlates with HAM/TSP disease severity.
A. Percentage of IFN-c
+CD4
+CD25
+CCR4
+ T cells to the total PBMCs in 8 HDs, 11 HAM/TSP patients, and 5 ATL patients. The horizontal bar indicates
the mean value of each group. Scheffe’s test (nonparametric) was used for statistical analysis. n.s. not significant. B. Correlation between HAM/TSP
disease severity and the frequency of IFN-c-producing CD4
+CD25
+CCR4
+ T cells in PBMCs or the HTLV-1 provirus load in PBMCs. According to
Spearman’s rank correlation test, the frequency of IFN-c
+CD4
+CD25
+CCR4
+ T cells correlated with disease severity (p=0.018), while the HTLV-1
provirus load did not (p=0.351). * indicates HAM/TSP patients with disease severity of a low grade and high provirus load. C. Correlation between
neopterin concentration in CSF and the frequency of IFN-c-producing CD4
+CD25
+CCR4
+ T cells in PBMCs or the HTLV-1 provirus load in PBMCs.
According to Spearman’s rank correlation test, the frequency of IFN-c
+CD4
+CD25
+CCR4
+ T cells correlated with CSF neopterin concentration
(p=0.011), while the HTLV-1 provirus load did not (p=0.358).
doi:10.1371/journal.pone.0006517.g007
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+CD25
+ T
cells exhibit reduced Foxp3 expression and Treg suppression
[20,27–29]. Furthermore, it has been demonstrated that HTLV-1-
infected CD4
+ T cells in HAM/TSP patients produce Th1
cytokines (IFN-c) [20,32]. Therefore, it was expected that
CD4
+CD25
+ T cells might exhibit reduced CCR4 expression in
HAM/TSP patients. However, we clearly demonstrated that
CCR4 was selectively overexpressed on HTLV-1-infected T cells.
We also demonstrated that the majority of CD4
+CD25
+CCR4
+ T
cells were infected with HTLV-1 and that this T cell subset was
increased in HAM/TSP patients (Figure 1). Furthermore,
CD4
+CD25
+CCR4
+ T cells, which mainly include suppressive T
cell subsets such as Th2 and Treg in HTLV-1-seronegative
healthy controls [26], become Th1-like cells with overproduction
of IFN-c and production of low levels of IL-4 and IL-10 (Figures 4
and 5) in patients with HAM/TSP. It is noteworthy that this
functional alteration in cytokine production was specific to the
HTLV-1-infected CD4
+CD25
+CCR4
+ T cell subtype (Figure 5B).
These results suggest that HTLV-1-infected CD4
+CD25
+CCR4
+
T cells in HAM/TSP patients were functionally proinflammatory
rather than suppressive. A hallmark of hyperimmune responsive-
ness in HAM/TSP is the capacity of PBMCs to spontaneously
proliferate, and the removal of CD4
+CD25
+CCR4
+ T cells
diminished this proliferative response (Figure 8A). Recently,
Shimizu et al reported that the depletion of CCR4
+ cells reduced
IFN-c production in the supernatant of cultured antigen-
responding cells in HAM/TSP patients [44]. Thus, functionally
altered CD4
+CD25
+CCR4
+ T cells in HAM/TSP patients are a
necessary component of the accelerated lymphoproliferative
response.
Patients with HAM/TSP exhibit a chronic inflammatory disorder
characterized by accumulation of activated CD4
+ and CD8
+ T cells
[38]. CD4
+CD25
+ T cells from HAM/TSP patients also exhibit an
activated phenotype marked by decreased expression of CD45RA
together with increased expression of IFN-c compared to the same
subset in healthy individuals [20]. Furthermore, we previously
demonstrated that HTLV-1 tax overexpression was capable of
reducing Foxp3 expression, and the HTLV-1 tax mRNA expression
in PBMCs of HAM/TSP was elevated [8,20]. Therefore, we
hypothesized that persistent T cell activation in patients with HAM/
TSP triggered by viral antigens such as HTLV-1 tax together with the
downregulation of Foxp3 may result in decline of the
CD4
+CD25
+CCR4
+Foxp3
+ Treg population and accumulation of
Foxp3-negative CD4
+CD25
+CCR4
+ T cells that lack suppressive
function, but are capable of exacerbating the disease process. In this
study, we have demonstrated that CD4
+CD25
+CCR4
+Foxp3
2 T cells
were proliferating in vivo (Ki67 positive) (Figure 3), and the frequency of
this population was increased in HAM/TSP patients (Figure 2).
Moreover, analysis of the cytokine expression in this
CD4
+CD25
+CCR4
+Foxp3
2 T cell subset demonstrated that these
cells were unique because they produce multiple proinflammatory
cytokines such as IL-2, IL-17, and few IFN-c in healthy individuals
whileCD4
+CD25
+CCR4
+Foxp3
+Tcells(Tregcells)didnot(Figure4).
Furthermore, it was demonstrated that HAM/TSP patients exhibited
Figure 8. Removal of CD4
+CD25
+CCR4
+ T cells decreases spontaneous proliferation of PBMCs from HAM/TSP patients. A. PBMCs,
PBMC lacking CD4
+CD25
+CCR4
+, and PBMCs lacking CD4
+CD25
2CCR4
2 obtained using FACS sorting from 4 HDs and 4 HAM/TSP patients were
cultured for 7 days, and the magnitude of proliferation was compared. Data are presented as mean6SE. The P values are calculated by paired t test.
n.s. not significant. B. CD4
+CD25
+CCR4
+ T cells of HAM/TSP patients proliferated independently. CD4
+CD25
+CCR4
+ cells and CD4
+CD25
2CCR4
2 T
cells were separated by FACS sorting from 4 HDs and 4 HAM/TSP patients, cultured for 7 days, and the magnitude of proliferation was compared.
Data are presented as mean6SE. The P values within each group are calculated by paired t test and those between the HD and HAM groups, by
unpaired Student’s t test. n.s. not significant.
doi:10.1371/journal.pone.0006517.g008
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+CD25
+CCR4
+Foxp3
+ T cells that do not produce such
cytokines (Figure 3). Rather, the CD4
+CD25
+CCR4
+Foxp3
2 T cells
in HAM/TSP were increased and found to overproduce IFN-c
(Figures 3 and 4). Further, the frequency of these IFN-c-producing
CD4
+CD25
+CCR4
+Foxp3
2 T cells may have a functional conse-
quence since this population was associated with increased clinical
disease activity and severity in HAM/TSP (Figure 7). These results
s u g g e s tt h a tI F N - c-producing CD4
+CD25
+CCR4
+Foxp3
2 T cells
may play an important pathogenic role in HAM/TSP by augmenting
inflammation in the CNS. Thus, we have defined a unique T cell
subset—IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+ T cells—that is specifi-
cally increased in HAM/TSP (tentatively designated THAM cells) and is
rarely encountered in healthy individuals. Since some HAM/TSP
patients are known to experience complications with other autoim-
mune disorders [5,6], it would be of interest to determine if this newly
d e f i n e dTc e l ls u b s e t( T HAM cells: IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
T cells) may also be abnormally increased and functionally deregulated
in other immunological diseases.
Although CD4
+CD25
+CCR4
+ T cells are predominantly infected
by HTLV-1 in both HAM/TSP and ATL (Figure 6), it was
demonstrated that the ratio of THAM cells (CCR4
+Foxp3
2 with IFN-
c production) to Treg cells (CCR4
+Foxp3
+ with no cytokine
production) in the CD4
+CD25
+CCR4
+ Tc e l ls u b s e tw e r eh i g hi n
HAM/TSP and low inATL (Figure 2). This differential THAM/Treg
ratio in HTLV-1-infected T cells may be associated with the different
immune responses observed between HAM/TSP and ATL. ATL
patients have very low frequencies of Tax-specific CD8
+ Tc e l l si n
PBMCs and tend to develop opportunistic infections [21], while
HAM/TSP is characterized by extraordinarily high levels of Tax-
specific CD8
+ CTL [7,8,11,40,41]. It has been reported that the
immunosuppressive function of CD4
+CD25
+ Tc e l l sw i t hh i g h
expression of Foxp3 in ATL patients is intact [42]. Thus, the
CD4
+CD25
+CCR4
+ leukemia T cells with increased Treg function
may also contribute to the clinically observed cellular immunodefi-
ciency in ATL patients. However, HAM/TSP patients show
extremely high cellular and humoral immune responses such as high
frequencies of Tax-specific CD8
+ T cells as well as cytomegalovirus
(CMV)-specific CD8
+ T cells in PBMCs [7,8,28]; high antibody titer
to HTLV-1 [6]; and increased production of proinflammatory
cytokines such as IL-6, IL-12, and IFN-c [9]. It has been reported
that HAM CD4
+CD25
+ T cells with low expression of Foxp3 [20] or
HTLV-1 Tax-expressing Foxp3
+ Treg cells [45] are defective in their
immunosuppressive function. Here, we demonstrate that HTLV-1-
infected IFN-c overproducing CD4
+CD25
+CCR4
+Foxp3
2 Tc e l l s
(THAM cells) are increased in HAM/TSP patients, and these levels
can be correlated with disease severity. Thus, CD4
+CD25
+CCR4
+ T
cells with increased proinflammatory function together with a
defective Treg compartment [20,27–29] may overcome the
regulatory effect of HTLV-1-uninfected Treg cells [45] and at least
partly account for the heightened immune response observed in
HAM/TSP patients. Collectively, these observations support the
hypothesis that imbalance of the THAM/Treg ratio in HTLV-1-
infected CD4
+CD25
+CCR4
+ T cells is an important factor that
contributes to immunological differences of the host immune
response between HAM/TSP and ATL (Figure S2).
The high Foxp3 expression without cytokine production and
low Foxp3 expression with cytokine production in
CD4
+CD25
+CCR4
+ T cells (Figure 3A) are consistent with recent
reports demonstrating that Foxp3 can target and repress the
transcriptional activity of NFAT-AP-1 complexes present at the
cytokine promoter [43]. We have previously reported that
overexpression of HTLV-1 tax was capable of reducing Foxp3
expression [20]. As we have demonstrated high HTLV-1 tax
expression in HAM/TSP CD4
+CD25
+CCR4
+ T cells (Foxp3
2)
and low HTLV-1 tax expression in ATL CD4
+CD25
+CCR4
+ T
cells (Foxp3
+) (Figure 6), it was suggested that HTLV-1 expression
intracellularly may act as a ‘‘switch’’ that directs T cell
differentiation of CD4
+CD25
+CCR4
+ T cells from Foxp3
+ to
IFN-c
+Foxp3
2 T cells. Further, the increased IFN-c production
and decreased IL-17 production in CD4
+CD25
+CCR4
+Foxp3
2 T
cells of HAM/TSP patients (Figures 4 and 5) suggests that HTLV-
1 expression may also contribute to the differentiation of Th1
versus Th17 CD4
+ T cells. These hypotheses are currently under
investigation to elucidate the precise molecular mechanisms by
which HTLV-1 influences the fate and function of
CD4
+CD25
+CCR4
+ T cells.
In conclusion, we have defined a unique T cell population
(THAM cells: IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+ T cells) that are
rarely encountered in normal individuals, are infected by HTLV-
1, and are found to be abnormally increased and proinflammatory
and correlate with disease severity in HAM/TSP patients. This
study is the first to demonstrate that THAM cells are crucial for the
pathogenesis of this retrovirus-associated chronic inflammatory
disorder of the nervous system.
Materials and Methods
Subjects, cell preparation, and determination of CSF
neopterin concentrations
A total of 11 HAM/TSP patients, 8 healthy donors, and 5
ATL patients (chronic type) participated in this study. Written
informed consents were obtained from all the subjects in
accordance with the Declaration of Helsinki as part of a clinical
protocol reviewed and approved by the Institutional Ethics
Committee (St. Marianna University). Blood samples were
collected from the subjects, peripheral blood mononuclear cells
(PBMCs) were separated by centrifugation over Ficoll-Hypaque
gradients, and the cells were cryopreserved in liquid nitrogen
until testing. HAM/TSP was diagnosed according to the
guidelines defined by the WHO, and ATL was diagnosed on
the basis of the criteria proposed by Shimoyama [46]. HTLV-1
seropositivity was determined by particle agglutination (Serodia-
HTLV-1; Fujirebio, Japan) and confirmed by western blotting
(SRL, Japan). Clinical disease severity was evaluated by Osame’s
motor disability scale (Table 1) [6]. In some experiments, CD4
+
T cells were negatively selected from the PBMCs by using
magnetic beads (MACS CD4
+ T cell isolation kit; Miltenyi
Biotec, Germany), according to the manufacturer’s instructions.
FACS cell sorting was performed using JSAN (Bay Bioscience,
Japan), and purity after sorting was approximately 99% (Figure
S1). Neopterin concentration was measured by high-perfor-
mance liquid chromatography with fluorometric detection
methods [33] (SRL, Japan).
Flow cytometry
Cells were immunostained with various combinations of the
following fluorescence-conjugated antibodies that served as cell
surface markers: CD4 (OKT4; eBioscience, San Diego, CA),
CD25 (M-A251; BD Biosciences, San Diego, CA), CCR4 (1G1;
BD Biosciences). In some experiments, cells were fixed by a
staining buffer set (eBioscience), then intracellularly stained with
the antibodies to Foxp3 (PCH101; eBioscience) and Ki67 (B56;
BD Biosciences). For intracellular cytokine staining, the cells were
stimulated for 5 h with phorbol 12-myristate 13-acetate (PMA) and
ionomycin (Sigma, Japan) in the presence of monensin (Golgistop;
BD Biosciences). Cells were fixed and stained with the antibodies
to IFN-c (B27; BD Biosciences), IL-2 (MQ1-17H12; BD
Biosciences), IL-10 (JES3-9D7, eBioscience), and IL-17A (eBio64-
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
PLoS ONE | www.plosone.org 12 August 2009 | Volume 4 | Issue 8 | e6517DEC17; eBioscience). Flow cytometric analysis was performed on
a FACSCalibur cytometer (BD Biosciences). Data processing was
performed using FlowJo software (TreeStar, San Diego, CA).
Real-time PCR
The HTLV-1 proviral DNA load was measured as previously
described [8]. For the real-time reverse transcriptase-PCR (RT-PCR)
analysis, CD4
+CD25
+CCR4
+ cells were separated by FACS sorting
from 3 HDs, 4 HAM/TSP patients, and 3 ATL patients. The
number of subjects for RT-PCR was limited because a large number
of PBMCs are required for sorting a sufficient number of
CD4
+CD25
+CCR4
+ cells for the analysis. Total RNA was isolated
from cells using ISOGENE (Nippon Gene, Japan). The first-strand
cDNA was synthesized with random hexamers and reverse
transcriptase (ReverTraAce; Toyobo, Japan) using 1 mgo ft o t a l
RNA in a reaction volume of 20 ml. Real-time PCR reactions were
carried out using TaqMan Universal Master Mix (Applied
Biosystems) and Universal Probe Library assays designed using
ProbeFinder software (Roche Applied Science). The primer
sequences and Universal Probe numbers used are available upon
request (Roche Applied Science). ABI Prism 7500 SDS was
programmed to an initial step of 2 min at 50uC and 10 min at
95uC,followedby45cyclesof15 secat 95uCa n d1m ina t6 0 uC. The
primers used were as follows: IFN-c,5 9-GGCATTTTGAA-
GAATTGGAAAG-39 (forward) and 59-TTTGGATGCTCTGGT-
CATCTT-39 (reverse) (probe No. 21); IL-2, 59-AAGTTTTA-
CATGCCCAAGAAGG-39 (forward) and 59-AAGTGAAAGTTT-
TTGCTTTGAGCTA-39 (reverse) (probe no. 65); IL-17A, 59-
TGGGAAGACCTCATTGGTGT-39 (forward) and 59-GGA-
TTTTCGTGGGATTGTGAT-39 (reverse) (probe No. 8); and
GAPDH, 59-AGCCACATCGCTCAGACA-39 (forward) and 59-
GCCCAATACGACCAAATCC-39 (reverse) (probe no. 60). The
primers and probe for detecting the HTLV-1 tax mRNA load were
used as described previously [8]. The primers and probe for IL-4 and
IL-10 were used from TaqManH Gene Expression Assays (IL-4: Hs:
Hs00932431_m1, IL-10: Hs00174086_m1). Relative quantification
of mRNA was performed using the comparative threshold cycle
method using GAPDH as an endogenous control. For each sample,
target gene expression was normalized to the expression of GAPDH.
To determinetherelativeexpression levels,the following formulawas
used: target gene expression=2
2(Ct[target] 2 Ct[GAPDH]).
Proliferation assays
Separated PBMCs, PBMCs lacking CD4
+CD25
+CCR4
+
cells, PBMCs lacking CD4
+CD25
2CCR4
2 cells,
CD4
+CD25
+CCR4
+ Tc e l l s ,a n dC D 4
+CD25
2CCR4
2 T cells
from HAM/TSP patients were plated into 96-well round
bottom plates (1610
5 per well) without any mitogenic stimuli.
RPMI 1640 with L-Glutamine (Wako, Japan) supplemented
with 5% human AB serum (Gibco-Invitrogen, NY), penicillin,
and streptomycin (Wako, Japan) was used as the culture
medium. After 6 days of culture, 1 mCi tritium thymidine was
added to each well, and the cells were cultured for an additional
16 hours. A liquid scintillation counter was used to measure the
proliferation. Cultures were performed in triplicate for each
experiment, and the average proliferation data was used for
analysis.
Statistical analyses
The Wilcoxon signed-rank test was used to compare the HTLV-1
provirus load between CD4
+CD25
+CCR4
+and CD4
+CD25
+CCR4
2
cells. An unpaired Student’s ttest was used to compare the frequency of
CD4
+CD25
+CCR4
+Foxp3
2 T cells in PBMCs, to compare the
percentage of the Foxp3
+ population in CD4
+CD25
+CCR4
+ T cells,
to compare the frequency of CD4
+CD25
2CCR4
2,
CD4
+CD25
2CCR4
+,C D 4
+CD25
+CCR4
2 or CD4
+CD25
+CCR4
+
T cells, to compare the percentage of IFN-c, IL-10 or IL-17 positive
cells in each cell population, and to compare the magnitude of
proliferation of CD4
+CD25
+CCR4
+T cells between HDs and HAM/
TSP patients. Paired Student’s t test was used to compare the
proliferative response of HAM PBMCs with and without
CD4
+CD25
+CCR4
+ T cells and HAM PBMCs with and without
CD4
+CD25
2CCR4
2 T cells, and to compare the proliferative
response between CD4
+CD25
+CCR4
+ T cells and
CD4
+CD25
2CCR4
2 T cells within HDs or HAM/TSP patients.
The nonparametric Scheffe’s test for multiple comparison was used to
compare the data between HAM/TSP patients, ATL patients, and
HDs. Spearman’s rank correlation test was used to investigate the
correlation between the percentage of IFN-c-producing
CD4
+CD25
+CCR4
+ T cells in PBMCs, HTLV-1 tax proviral load
in PBMCs, clinical severity score, and concentration of neopterin in the
CSF. Statistical analyses were performed using Statcel2 software.
Supporting Information
Figure S1 Purity of cell populations separated by FACS sorting.
CD4+CD252CCR42, CD4+CD252CCR4+, CD4+CD25+
CCR42, and CD4+CD25+CCR4+T cells were separated by
FACS. The purity of each population was indicated as the
histogram of fractions from (a)–(d): (a) CD4+CD25+CCR42, (b)
CD4+CD25+CCR4+, (c) CD4+CD252CCR42, and (d)
CD4+CD252CCR4+T cells. The purity of each population is
approximately 99%.
Found at: doi:10.1371/journal.pone.0006517.s001 (0.60 MB TIF)
Figure S2 Schematic hypothesis outlining the importance of
the different characteristics of HTLV-1-infected T cells in
HAM/TSP and ATL patients. An imbalance in the THAM/
Treg ratio in HTLV-1-infected CD4+CD25+CCR4+Tc e l l sm a y
be an important factor that contributes to immunological
differences of the host immune response between HAM/TSP
and ATL.
Found at: doi:10.1371/journal.pone.0006517.s002 (0.34 MB TIF)
Table 1. Motor disability grading for HAM/TSP.
Grade Motor disability
0 Normal gait and running
1 Normal gait but runs slowly
2 Abnormal gait (staggering or spastic)
3 Abnormal gait and unable to run
4 Needs support while using stairs but walks without assistance
5 Needs one hand support in walking
6 Needs two hands support in walking (can walk more than 10 meter)
7 Needs two hands support in walking (can walk less than 10 meter)
8 Needs two hands support in walking (can walk less than 5 meter)
9 Unable to walk but can walk on all fours
10 Unable to walk on all fours but can crawl with hands
11 Unable to crawl with hands but can turn sideways in bed
12 Unable to turn sideways but can move the toes
13 Completely bedridden (unable to move the toes)
doi:10.1371/journal.pone.0006517.t001
IFN-c
+CCR4
+Foxp3
2CD4
+CD25
+
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